Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: differentiation between neuromodulatory and neurotrophic influences

J Neurosci. 2001 May 15;21(10):3375-82. doi: 10.1523/JNEUROSCI.21-10-03375.2001.

Abstract

Long-term exposure to nerve growth factor (NGF) is well established to have neurotrophic effects on basal forebrain cholinergic neurons, but its potential actions as a fast-acting neuromodulator are not as well understood. We report that NGF (0.1-100 ng/ml) rapidly (<60 min) and robustly enhanced constitutive acetylcholine (ACh) release (148-384% of control) from basal forebrain cultures without immediate persistent increases in choline acetyltransferase activity. More ACh was released in response to NGF when exposure was coupled with a higher depolarization level, suggesting activity dependence. In a long-term potentiation-like manner, brief NGF exposure (10 ng/ml; 60 min) induced robust and prolonged increases in ACh release, a capacity that was shared with the other neurotrophins. K252a (10-100 nm), BAPTA-AM (25 microm), and Cd(2+) (200 microm) prevented NGF enhancement of ACh release, suggesting the involvement of TrkA receptors, Ca(2+), and voltage-gated Ca(2+) channels, respectively. Forskolin (10 microm), a cAMP generator, enhanced constitutive ACh release but did not interact synergistically with NGF. Tetrodotoxin (1 microm) and cycloheximide (2 microm) did not prevent NGF-induced ACh release, indicative of action at the level of the cholinergic nerve terminal and that new protein synthesis is not required for this neurotransmitter-like effect, respectively. In contrast, after a 24 hr NGF treatment, distinct protein synthesis-dependent and independent effects on choline acetyltransferase activity and ACh release were observed. These results indicate that neuromodulator/neurotransmitter-like (protein synthesis-independent) and neurotrophic (translation-dependent) actions likely make distinct contributions to the enhancement of cholinergic activity by NGF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / biosynthesis*
  • Animals
  • Cadmium / pharmacology
  • Calcium / metabolism
  • Calcium Channels / metabolism
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Choline O-Acetyltransferase / metabolism
  • Colforsin / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Long-Term Potentiation / drug effects
  • Nerve Growth Factor / pharmacology
  • Nerve Growth Factors / pharmacology*
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neurotransmitter Agents / pharmacology*
  • Prosencephalon / cytology
  • Prosencephalon / metabolism*
  • Protein Synthesis Inhibitors / pharmacology
  • Rats
  • Receptor, trkA / metabolism
  • Tetrodotoxin / pharmacology

Substances

  • Calcium Channels
  • Chelating Agents
  • Enzyme Inhibitors
  • Nerve Growth Factors
  • Neurotransmitter Agents
  • Protein Synthesis Inhibitors
  • Cadmium
  • Colforsin
  • Tetrodotoxin
  • Nerve Growth Factor
  • Choline O-Acetyltransferase
  • Receptor, trkA
  • Acetylcholine
  • Calcium